BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23849974)

  • 1. Perilesional intrathecal administration of autologous bone marrow stromal cells achieves functional improvement in pigs with chronic paraplegia.
    Zurita M; Aguayo C; Bonilla C; Rodriguez A; Vaquero J
    Cytotherapy; 2013 Oct; 15(10):1218-27. PubMed ID: 23849974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells.
    Zurita M; Vaquero J; Bonilla C; Santos M; De Haro J; Oya S; Aguayo C
    Transplantation; 2008 Sep; 86(6):845-53. PubMed ID: 18813110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration?
    Vaquero J; Zurita M; Oya S; Santos M
    Neurosci Lett; 2006 May; 398(1-2):129-34. PubMed ID: 16423458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation.
    Zurita M; Vaquero J
    Neurosci Lett; 2006 Jul; 402(1-2):51-6. PubMed ID: 16713677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
    Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
    Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology.
    Vaquero J; Zurita M
    Histol Histopathol; 2009 Jan; 24(1):107-16. PubMed ID: 19012250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits.
    Fang B; Wang H; Sun XJ; Li XQ; Ai CY; Tan WF; White PF; Ma H
    J Vasc Surg; 2013 Oct; 58(4):1043-52. PubMed ID: 23478501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.
    Yazdani SO; Hafizi M; Zali AR; Atashi A; Ashrafi F; Seddighi AS; Soleimani M
    Cytotherapy; 2013 Jul; 15(7):782-91. PubMed ID: 23731761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of transplantation of autologous bone marrow stromal cells into the cerebrospinal fluid for treatment of chronic spinal cord injury in dogs.
    Nishida H; Nakayama M; Tanaka H; Kitamura M; Hatoya S; Sugiura K; Suzuki Y; Ide C; Inaba T
    Am J Vet Res; 2011 Aug; 72(8):1118-23. PubMed ID: 21801071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow mononuclear cell transplant and surgical decompression in a dog with chronic spinal cord injury.
    Tamura K; Harada Y; Kunimi M; Takemitsu H; Hara Y; Nakamura T; Tagawa M
    Exp Clin Transplant; 2015 Feb; 13(1):100-5. PubMed ID: 25019162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation.
    Zurita M; Vaquero J
    Neuroreport; 2004 May; 15(7):1105-8. PubMed ID: 15129154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial.
    Vaquero J; Zurita M; Rico MA; Bonilla C; Aguayo C; Montilla J; Bustamante S; Carballido J; Marin E; Martinez F; Parajon A; Fernandez C; Reina L;
    Cytotherapy; 2016 Aug; 18(8):1025-1036. PubMed ID: 27311799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal injection of bone marrow stromal cells attenuates neurologic injury after spinal cord ischemia.
    Shi E; Kazui T; Jiang X; Washiyama N; Yamashita K; Terada H; Bashar AH
    Ann Thorac Surg; 2006 Jun; 81(6):2227-33; discussion 2233-4. PubMed ID: 16731159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury.
    Kishk NA; Gabr H; Hamdy S; Afifi L; Abokresha N; Mahmoud H; Wafaie A; Bilal D
    Neurorehabil Neural Repair; 2010 Oct; 24(8):702-8. PubMed ID: 20660620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering.
    Itosaka H; Kuroda S; Shichinohe H; Yasuda H; Yano S; Kamei S; Kawamura R; Hida K; Iwasaki Y
    Neuropathology; 2009 Jun; 29(3):248-57. PubMed ID: 18992011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats.
    de Haro J; Zurita M; Ayllón L; Vaquero J
    Neurosci Lett; 2005 Mar; 377(1):7-11. PubMed ID: 15722177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of autologous neurogenically-induced bone marrow-derived mesenchymal stem cells for the treatment of paraplegic dogs without nociception due to spinal trauma.
    Besalti O; Aktas Z; Can P; Akpinar E; Elcin AE; Elcin YM
    J Vet Med Sci; 2016 Oct; 78(9):1465-1473. PubMed ID: 27301583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study.
    Samdani AF; Paul C; Betz RR; Fischer I; Neuhuber B
    Spine (Phila Pa 1976); 2009 Nov; 34(24):2605-12. PubMed ID: 19881401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord.
    Koda M; Kamada T; Hashimoto M; Murakami M; Shirasawa H; Sakao S; Ino H; Yoshinaga K; Koshizuka S; Moriya H; Yamazaki M
    Eur Spine J; 2007 Dec; 16(12):2206-14. PubMed ID: 17885772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data.
    Kumar AA; Kumar SR; Narayanan R; Arul K; Baskaran M
    Exp Clin Transplant; 2009 Dec; 7(4):241-8. PubMed ID: 20353375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.